Twelve-month interim analysis of efficacy and safety of givosiran, an investigational RNAi therapeutic for acute hepatic porphyria, in the envision open label extension by Sardh, Eliane, Balwani, Manisha, Rees, David, Stein, Penelope, Stözel, Ulrich, Aguilera, Paula, Bissell, D. Montgomery, Bonkovsky, Herbert, Keel, Sioban, Parket, Charles, Phillips, John, Silver, Samuel, Windyga, Jerzy, D’Avola, Delia, Ross, Gayle, Stewart, Peter, Ritchie, Bruce, Harper, Pauline, Wang, Jiaan-Der, Langendonk, Janneke Langendonk, Ivanova, Aneta, Horie, Yutaka, Anderson, Karl, Ventura, Paolo, Cappellini, Maria Domenica, Vassiliou, Daphne, Monroy-Santoyo, Susana, Petrides, Petro, Adachi, Tomohide, Kuter, David, Scalera, Sushama, Penz, Craig, Liu, Gary, Ko, John, Simon, Amy, Gouya, Laurent

Get full text

AS085 - Twelve-month interim analysis of efficacy and safety of givosiran, an investigational RNAi therapeutic for acute hepatic porphyria, in the envision open label extension by Sardh, Eliane, Balwani, Manisha, Rees, David, Stein, Penelope, Stözel, Ulrich, Aguilera, Paula, Bissell, D. Montgomery, Bonkovsky, Herbert, Keel, Sioban, Parket, Charles, Phillips, John, Silver, Samuel, Windyga, Jerzy, D’Avola, Delia, Ross, Gayle, Stewart, Peter, Ritchie, Bruce, Harper, Pauline, Wang, Jiaan-Der, Langendonk, Janneke Langendonk, Ivanova, Aneta, Horie, Yutaka, Anderson, Karl, Ventura, Paolo, Cappellini, Maria Domenica, Vassiliou, Daphne, Monroy-Santoyo, Susana, Petrides, Petro, Adachi, Tomohide, Kuter, David, Scalera, Sushama, Penz, Craig, Liu, Gary, Ko, John, Simon, Amy, Gouya, Laurent

Get full text